Edition:
United States

Inflarx NV (IFRX.OQ)

IFRX.OQ on NASDAQ Stock Exchange Global Select Market

29.20USD
16 Feb 2018
Change (% chg)

$-0.06 (-0.21%)
Prev Close
$29.26
Open
$29.82
Day's High
$29.82
Day's Low
$28.31
Volume
5,761
Avg. Vol
--
52-wk High
$32.38
52-wk Low
$14.50

Latest Key Developments (Source: Significant Developments)

Inflarx Receives IND Acceptance To Proceed With A Phase IIB Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa
Tuesday, 9 Jan 2018 08:56am EST 

Jan 9 (Reuters) - Inflarx Nv ::INFLARX RECEIVES IND ACCEPTANCE TO PROCEED WITH A PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA.INFLARX NV - ‍INTENDS TO INITIATE THE STUDY ON IFX-1 IN Q1 OF 2018​.  Full Article

Ra Capital Management Reports 12.3 Pct Passive Stake In Inflarx Nv
Monday, 11 Dec 2017 05:33pm EST 

Dec 11 (Reuters) - Inflarx Nv ::RA CAPITAL MANAGEMENT LLC REPORTS 12.3 PERCENT PASSIVE STAKE IN INFLARX NV AS OF NOVEMBER 8 - SEC FILING.  Full Article

BRIEF-Inflarx Receives IND Acceptance To Proceed With A Phase IIB Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa

* INFLARX RECEIVES IND ACCEPTANCE TO PROCEED WITH A PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA